65 results
Page 2 of 4
8-K
EX-2.1
d0f9nhqa hdxpxep
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
g1m7c054k
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-10.1
36zvyz0i 66
28 Jan 21
Cost Associated with Exit or Disposal Activities
8:01am
8-K
EX-10.1
k8o0bb1 pe5v91k5pjxj
17 Apr 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.4
v7wsrf85g8k6h7hk1tm
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.2
ia5hs6yu
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.3
9172paeb4vw5ewp
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
DEFM14A
z1o2m
6 Nov 18
Proxy related to merger
12:00am
424B3
cg2n9837i2m52d09zb
5 Nov 18
Prospectus supplement
3:51pm
8-K
EX-2.1
11shnwk
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
67q4a cbtaq0wup
9 Aug 18
Business combination disclosure
5:17pm